FOOD AND DRUG ADMINISTRATION
NOTICES OF JUDGMENT UNDER THE FEDERAL FOOD,
DRUG, AND COSMETIC ACT
[Given pursuant to section 705 of the Food, Drug, and Cosmetic Act]
4081-4100
DRUGS AND DEVICES
The cases reported herewith were instituted in the United States district
courts by the United States attorneys, acting upon reports submitted by the
Department of Health, Education, and Welfare. Published by direction of the
Secretary of Health, Education, and Welfare.
CHARLES W. CRAWFORD, Commissioner of Food and Drugs.
WASHINGTON, D. C, March 22,1954.
CONTENTS*
Page
Violative    sales    of    prescription
drugs 
    82
Drugs in violation of prescription
labeling requirements     83
Drugs and devices actionable be-
cause of failure to bear ade-
quate directions or warning
statements 
    88
Page
Drugs actionable because of devia-
tion from official or own stand-
ards 
    94
Drugs and devices actionable be-
cause of false and misleading
claims 
    95
Index 
  105
? For presence of a habit-forming narcotic without warning statement, see Nos. 4085, 4087; omission of.
or unsatisfactory, ingredients statements, Nos. 4083, 4085, 4087; sale under name of another drug, No. 4084;
failure to bear a label containing an accurate statement of the quantity of the contents, Nos. 4083, 4085-
4087; failure to bear a label containing the name and place of business of the manufacturer, packer, or dis-
tributor, Nos. 4083, 4086, 4087.
81
291251-54 1
VIOLATIVE SALES OF PRESCRIPTION DRUGS
4081. Misbranding   of   Benzedrine   Sulfate   tablets   and   Dexedrine   Sulfate
tablets. U. S. v. James Hendelberg. Plea of guilty. Fine of $1,000
or sentence of 60 days in jail. (F. D. C. No. 33752. Sample Nos. 3005-L,
3006-L.)
INFORMATION FILED: November 20, 1952, District of Columbia, against James
Hendelberg, Washington, D. C.
NATURE OF CHARGE : On or about September 27,1952, the defendant unlawfully
sold, within the District of Columbia, certain dangerous, harmful, or toxic
drugs* without a physician's prescription, namely, Dexedrine Sulfate tablets
and Benzedrine Sulfate tablets. Such acts of sale were in violation of Section
503 (b) (1) and resulted in the drugs being misbranded.
DISPOSITION : December 9,1952. The defendant having entered a plea of guilty,
the court sentenced him to serve 60 days in jail or, in the alternative, to pay
a fine of $1,000.